Seeking Alpha

IMMU
  Immunomedics, Inc. - NASDAQ

8/21/2014, 3:36 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
IMMU vs. ETF Alternatives
Company Description
Immunomedics, Inc., is a biopharmaceutical company which is focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.